We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) Downgraded to Hold: Find Out Why
Read MoreHide Full Article
Tennessee-based Chemical maker Eastman Chemical (EMN - Free Report) was downgraded to a Zacks Rank #3 (Hold) on May 24. The company recorded earnings of $278 million or $1.89 per share in the first quarter of 2017, higher than the year-ago figure of $251 million or $1.69.
Barring one-time items, earnings were $1.83 per share for the quarter that topped the Zacks Consensus Estimate of $1.74 per share.
Revenues rose around 2.9% year over year to $2.3 billion, beating the Zacks Consensus Estimate of $2.24 billion.
Eastman Chemical remains focused on cost-cutting and productivity actions amid a challenging operating environment, which are expected to contribute around 50 cents to earnings per share in 2017. Further, the company expects adjusted earnings per share to grow 8–12% in the year.
Eastman Chemical is also expected to gain from strategic acquisitions and capacity expansion actions. Moreover, the company remains committed to reduce debt and boost shareholders returns, leveraging healthy free cash flows. In 2017, it expects to generate solid free cash flow and return around $650 million to its shareholders.
Eastman Chemical’s shares have gained 5.9% in the last six months, underperforming the Zacks categorized Chemicals-Diversified industry’s gain of 9.1%.
However, pricing pressure continues to hurt the company’s top-line. Challenging global economic conditions are affecting some of the company’s businesses. The company sees volume pressure in the Fibers business in first-half 2017 and a roughly 25% decline in earnings for the unit for full-year 2017. The company also faces currency translation risks given a strong U.S. dollar.
Eastman Chemical has witnessed four downward and three upward revisions for current quarter earnings over the past 30 days. However, the Zacks Consensus Estimate for second-quarter 2017 has remained stable at $1.89, over the past 30 days.
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman Chemical (EMN) Downgraded to Hold: Find Out Why
Tennessee-based Chemical maker Eastman Chemical (EMN - Free Report) was downgraded to a Zacks Rank #3 (Hold) on May 24. The company recorded earnings of $278 million or $1.89 per share in the first quarter of 2017, higher than the year-ago figure of $251 million or $1.69.
Barring one-time items, earnings were $1.83 per share for the quarter that topped the Zacks Consensus Estimate of $1.74 per share.
Revenues rose around 2.9% year over year to $2.3 billion, beating the Zacks Consensus Estimate of $2.24 billion.
Eastman Chemical remains focused on cost-cutting and productivity actions amid a challenging operating environment, which are expected to contribute around 50 cents to earnings per share in 2017. Further, the company expects adjusted earnings per share to grow 8–12% in the year.
Eastman Chemical is also expected to gain from strategic acquisitions and capacity expansion actions. Moreover, the company remains committed to reduce debt and boost shareholders returns, leveraging healthy free cash flows. In 2017, it expects to generate solid free cash flow and return around $650 million to its shareholders.
Eastman Chemical’s shares have gained 5.9% in the last six months, underperforming the Zacks categorized Chemicals-Diversified industry’s gain of 9.1%.
However, pricing pressure continues to hurt the company’s top-line. Challenging global economic conditions are affecting some of the company’s businesses. The company sees volume pressure in the Fibers business in first-half 2017 and a roughly 25% decline in earnings for the unit for full-year 2017. The company also faces currency translation risks given a strong U.S. dollar.
Eastman Chemical has witnessed four downward and three upward revisions for current quarter earnings over the past 30 days. However, the Zacks Consensus Estimate for second-quarter 2017 has remained stable at $1.89, over the past 30 days.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company Price and Consensus | Eastman Chemical Company Quote
Stocks to Consider
Some better-ranked companies in the chemical space include BASF SE (BASFY - Free Report) , The Chemours Company (CC - Free Report) and Kronos Worldwide Inc (KRO - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
BASF has expected long-term growth of 8.6%.
Chemours has expected long-term growth of 15.5%.
Kronos has expected long-term growth of 5%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>